Scientia Advisors in the News
GenomeWeb Quotes Patrick Terry in Payors Weigh in on Interface of Personalized Medicine and Comparative Effectiveness Research
Turna RayDecember 8, 2010
In this GenomeWeb article, the author, Turna Ray, reviews payors' likely use of comparative effectiveness research (CER) given their feeling that personalized medicine lacks the evidentiary support to justify broad coverage. Payors consider that CER may help them gather the necessary data to decide on reimbursement for genomically guided medicines. The author concludes her article with a quote from Patrick Terry of Scientia Advisors, saying: "Right now it's all exploratory and people are trying to make sense of it all. It will be a new set of relationships that will take place in the marketplace around evidence and comparative effectiveness."
Full article available at: GenomeWeb - For subscribers only.
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
